ID   KYNU_HUMAN              Reviewed;         465 AA.
AC   Q16719; B2RCZ5; D3DP79; Q6I9T2; Q9BVW3;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   12-APR-2017, entry version 160.
DE   RecName: Full=Kynureninase {ECO:0000255|HAMAP-Rule:MF_03017};
DE            EC=3.7.1.3 {ECO:0000255|HAMAP-Rule:MF_03017};
DE   AltName: Full=L-kynurenine hydrolase {ECO:0000255|HAMAP-Rule:MF_03017};
GN   Name=KYNU {ECO:0000255|HAMAP-Rule:MF_03017};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, CATALYTIC ACTIVITY, ENZYME REGULATION, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Hepatoma;
RX   PubMed=8706755; DOI=10.1111/j.1432-1033.1996.0460u.x;
RA   Alberati-Giani D., Buchli R., Malherbe P., Broger C., Lang G.,
RA   Koehler C., Lahm H.-W., Cesura A.M.;
RT   "Isolation and expression of a cDNA clone encoding human
RT   kynureninase.";
RL   Eur. J. Biochem. 239:460-468(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, CATALYTIC
RP   ACTIVITY, ENZYME REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Liver;
RX   PubMed=9180257; DOI=10.1016/S0014-5793(97)00374-8;
RA   Toma S., Nakamura M., Tone S., Okuno E., Kido R., Breton J.,
RA   Avanzi N., Cozzi L., Speciale C., Mostardini M., Gatti S., Benatti L.;
RT   "Cloning and recombinant expression of rat and human kynureninase.";
RL   FEBS Lett. 408:5-10(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLU-412.
RC   TISSUE=Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   MASS SPECTROMETRY, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=11985583; DOI=10.1046/j.1432-1033.2002.02854.x;
RA   Walsh H.A., Botting N.P.;
RT   "Purification and biochemical characterization of some of the
RT   properties of recombinant human kynureninase.";
RL   Eur. J. Biochem. 269:2069-2074(2002).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH PYRIDOXAL
RP   PHOSPHATE, HOMODIMERIZATION, CATALYTIC ACTIVITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=17300176; DOI=10.1021/bi0616697;
RA   Lima S., Khristoforov R., Momany C., Phillips R.S.;
RT   "Crystal structure of Homo sapiens kynureninase.";
RL   Biochemistry 46:2735-2744(2007).
RN   [13]
RP   INVOLVEMENT IN HYXKY, AND VARIANT HYXKY ALA-198.
RX   PubMed=17334708; DOI=10.1007/s10545-007-0396-2;
RA   Christensen M., Duno M., Lund A.M., Skovby F., Christensen E.;
RT   "Xanthurenic aciduria due to a mutation in KYNU encoding
RT   kynureninase.";
RL   J. Inherit. Metab. Dis. 30:248-255(2007).
CC   -!- FUNCTION: Catalyzes the cleavage of L-kynurenine (L-Kyn) and L-3-
CC       hydroxykynurenine (L-3OHKyn) into anthranilic acid (AA) and 3-
CC       hydroxyanthranilic acid (3-OHAA), respectively. Has a preference
CC       for the L-3-hydroxy form. Also has cysteine-conjugate-beta-lyase
CC       activity.
CC   -!- CATALYTIC ACTIVITY: L-kynurenine + H(2)O = anthranilate + L-
CC       alanine. {ECO:0000255|HAMAP-Rule:MF_03017}.
CC   -!- CATALYTIC ACTIVITY: L-3-hydroxykynurenine + H(2)O = 3-
CC       hydroxyanthranilate + L-alanine. {ECO:0000255|HAMAP-
CC       Rule:MF_03017}.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC   -!- ENZYME REGULATION: Inhibited by o-methoxybenzoylalanine (OMBA).
CC       {ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=493 uM for L-kynurenine (at pH 7.0)
CC         {ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176,
CC         ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257};
CC         KM=28.3 uM for DL-3-hydroxykynurenine (at pH 7.0)
CC         {ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176,
CC         ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257};
CC         KM=3.0 uM for DL-3-hydroxykynurenine (at pH 7.9)
CC         {ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176,
CC         ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257};
CC       pH dependence:
CC         Optimum pH is 8.25 with DL-3-hydroxykynurenine as substrate.
CC         {ECO:0000269|PubMed:11985583, ECO:0000269|PubMed:17300176,
CC         ECO:0000269|PubMed:8706755, ECO:0000269|PubMed:9180257};
CC   -!- PATHWAY: Amino-acid degradation; L-kynurenine degradation; L-
CC       alanine and anthranilate from L-kynurenine: step 1/1.
CC       {ECO:0000255|HAMAP-Rule:MF_03017}.
CC   -!- PATHWAY: Cofactor biosynthesis; NAD(+) biosynthesis; quinolinate
CC       from L-kynurenine: step 2/3. {ECO:0000255|HAMAP-Rule:MF_03017}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_03017,
CC       ECO:0000269|PubMed:17300176}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_03017,
CC       ECO:0000269|PubMed:8706755}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q16719-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q16719-2; Sequence=VSP_042739, VSP_042740;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues tested (heart, brain
CC       placenta, lung, liver, skeletal muscle, kidney and pancreas).
CC       Highest levels found in placenta, liver and lung. Expressed in all
CC       brain regions. {ECO:0000269|PubMed:8706755,
CC       ECO:0000269|PubMed:9180257}.
CC   -!- INDUCTION: Increased levels in several cerebral and systemic
CC       inflammatory conditions.
CC   -!- MASS SPECTROMETRY: Mass=52400; Method=MALDI; Range=1-465; Note=The
CC       reported mass is given to only three significant figures.;
CC       Evidence={ECO:0000269|PubMed:11985583};
CC   -!- DISEASE: Hydroxykynureninuria (HYXKY) [MIM:236800]: An inborn
CC       error of amino acid metabolism characterized by massive urinary
CC       excretion of large amounts of kynurenine, 3-hydroxykynurenine and
CC       xanthurenic acid. Affected individuals manifest renal tubular
CC       dysfunction, metabolic acidosis, psychomotor retardation, non-
CC       progressive encephalopathy, and muscular hypertonia.
CC       {ECO:0000269|PubMed:17334708}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the kynureninase family.
CC       {ECO:0000255|HAMAP-Rule:MF_03017}.
CC   -!- CAUTION: It has been reported that this enzyme possesses no
CC       measurable activity against L-kynurenine and is subject to
CC       inhibition by both L-kynurenine and D-kynurenine at pH 7.9.
CC       {ECO:0000305|PubMed:11985583}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U57721; AAC50650.1; -; mRNA.
DR   EMBL; AK315343; BAG37742.1; -; mRNA.
DR   EMBL; CR457423; CAG33704.1; -; mRNA.
DR   EMBL; AC013437; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC013444; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471058; EAX11599.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11600.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX11601.1; -; Genomic_DNA.
DR   EMBL; BC000879; AAH00879.1; -; mRNA.
DR   CCDS; CCDS2183.1; -. [Q16719-1]
DR   CCDS; CCDS33299.1; -. [Q16719-2]
DR   PIR; G02652; G02652.
DR   RefSeq; NP_001028170.1; NM_001032998.1. [Q16719-2]
DR   RefSeq; NP_001186170.1; NM_001199241.1. [Q16719-1]
DR   RefSeq; NP_003928.1; NM_003937.2. [Q16719-1]
DR   RefSeq; XP_016860706.1; XM_017005217.1. [Q16719-2]
DR   UniGene; Hs.470126; -.
DR   PDB; 2HZP; X-ray; 2.00 A; A=1-465.
DR   PDB; 3E9K; X-ray; 1.70 A; A=1-465.
DR   PDBsum; 2HZP; -.
DR   PDBsum; 3E9K; -.
DR   ProteinModelPortal; Q16719; -.
DR   SMR; Q16719; -.
DR   BioGrid; 114454; 45.
DR   IntAct; Q16719; 6.
DR   STRING; 9606.ENSP00000264170; -.
DR   BindingDB; Q16719; -.
DR   ChEMBL; CHEMBL5100; -.
DR   DrugBank; DB07069; 3-Hydroxyhippuric acid.
DR   DrugBank; DB00160; L-Alanine.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   iPTMnet; Q16719; -.
DR   PhosphoSitePlus; Q16719; -.
DR   BioMuta; KYNU; -.
DR   DMDM; 3913982; -.
DR   EPD; Q16719; -.
DR   MaxQB; Q16719; -.
DR   PaxDb; Q16719; -.
DR   PeptideAtlas; Q16719; -.
DR   PRIDE; Q16719; -.
DR   DNASU; 8942; -.
DR   Ensembl; ENST00000264170; ENSP00000264170; ENSG00000115919. [Q16719-1]
DR   Ensembl; ENST00000375773; ENSP00000364928; ENSG00000115919. [Q16719-2]
DR   Ensembl; ENST00000409512; ENSP00000386731; ENSG00000115919. [Q16719-1]
DR   GeneID; 8942; -.
DR   KEGG; hsa:8942; -.
DR   UCSC; uc002tvk.4; human. [Q16719-1]
DR   CTD; 8942; -.
DR   DisGeNET; 8942; -.
DR   GeneCards; KYNU; -.
DR   HGNC; HGNC:6469; KYNU.
DR   HPA; HPA031686; -.
DR   MalaCards; KYNU; -.
DR   MIM; 236800; phenotype.
DR   MIM; 605197; gene.
DR   neXtProt; NX_Q16719; -.
DR   OpenTargets; ENSG00000115919; -.
DR   Orphanet; 79155; Encephalopathy due to hydroxykynureninuria.
DR   PharmGKB; PA30258; -.
DR   eggNOG; KOG3846; Eukaryota.
DR   eggNOG; COG3844; LUCA.
DR   GeneTree; ENSGT00390000008033; -.
DR   HOGENOM; HOG000242438; -.
DR   HOVERGEN; HBG001170; -.
DR   InParanoid; Q16719; -.
DR   KO; K01556; -.
DR   OMA; GWYGGDK; -.
DR   OrthoDB; EOG091G077R; -.
DR   PhylomeDB; Q16719; -.
DR   TreeFam; TF300707; -.
DR   BioCyc; MetaCyc:HS03952-MONOMER; -.
DR   BRENDA; 3.7.1.3; 2681.
DR   Reactome; R-HSA-71240; Tryptophan catabolism.
DR   SABIO-RK; Q16719; -.
DR   UniPathway; UPA00253; UER00329.
DR   UniPathway; UPA00334; UER00455.
DR   ChiTaRS; KYNU; human.
DR   EvolutionaryTrace; Q16719; -.
DR   GeneWiki; Kynureninase; -.
DR   GenomeRNAi; 8942; -.
DR   PRO; PR:Q16719; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000115919; -.
DR   CleanEx; HS_KYNU; -.
DR   ExpressionAtlas; Q16719; baseline and differential.
DR   Genevisible; Q16719; HS.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0030429; F:kynureninase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:Ensembl.
DR   GO; GO:0043420; P:anthranilate metabolic process; IDA:UniProtKB.
DR   GO; GO:0097053; P:L-kynurenine catabolic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0009435; P:NAD biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0019805; P:quinolinate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0034341; P:response to interferon-gamma; IDA:UniProtKB.
DR   GO; GO:0034516; P:response to vitamin B6; IMP:UniProtKB.
DR   GO; GO:0006569; P:tryptophan catabolic process; IMP:UniProtKB.
DR   GO; GO:0019442; P:tryptophan catabolic process to acetyl-CoA; IEA:Ensembl.
DR   GO; GO:0019441; P:tryptophan catabolic process to kynurenine; IBA:GO_Central.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 1.
DR   HAMAP; MF_01970; Kynureninase; 1.
DR   InterPro; IPR000192; Aminotrans_V_dom.
DR   InterPro; IPR010111; Kynureninase.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major_sub1.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_sub2.
DR   PANTHER; PTHR14084; PTHR14084; 1.
DR   Pfam; PF00266; Aminotran_5; 1.
DR   PIRSF; PIRSF038800; KYNU; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
DR   TIGRFAMs; TIGR01814; kynureninase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Disease mutation; Hydrolase; Polymorphism;
KW   Pyridine nucleotide biosynthesis; Pyridoxal phosphate;
KW   Reference proteome.
FT   CHAIN         1    465       Kynureninase.
FT                                /FTId=PRO_0000218657.
FT   REGION      165    168       Pyridoxal phosphate binding.
FT   BINDING     137    137       Pyridoxal phosphate; via amide nitrogen.
FT                                {ECO:0000255|HAMAP-Rule:MF_03017}.
FT   BINDING     138    138       Pyridoxal phosphate. {ECO:0000255|HAMAP-
FT                                Rule:MF_03017,
FT                                ECO:0000269|PubMed:17300176}.
FT   BINDING     221    221       Pyridoxal phosphate. {ECO:0000255|HAMAP-
FT                                Rule:MF_03017}.
FT   BINDING     250    250       Pyridoxal phosphate. {ECO:0000255|HAMAP-
FT                                Rule:MF_03017,
FT                                ECO:0000269|PubMed:17300176}.
FT   BINDING     253    253       Pyridoxal phosphate. {ECO:0000255|HAMAP-
FT                                Rule:MF_03017,
FT                                ECO:0000269|PubMed:17300176}.
FT   BINDING     275    275       Pyridoxal phosphate. {ECO:0000255|HAMAP-
FT                                Rule:MF_03017,
FT                                ECO:0000269|PubMed:17300176}.
FT   BINDING     305    305       Pyridoxal phosphate. {ECO:0000255|HAMAP-
FT                                Rule:MF_03017,
FT                                ECO:0000269|PubMed:17300176}.
FT   BINDING     333    333       Pyridoxal phosphate. {ECO:0000255|HAMAP-
FT                                Rule:MF_03017,
FT                                ECO:0000269|PubMed:17300176}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     276    276       N6-(pyridoxal phosphate)lysine.
FT   VAR_SEQ     302    307       LVGWFG -> RSEFFN (in isoform 2).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_042739.
FT   VAR_SEQ     308    465       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_042740.
FT   VARIANT     188    188       R -> Q (in dbSNP:rs2304705).
FT                                /FTId=VAR_049724.
FT   VARIANT     198    198       T -> A (in HYXKY; dbSNP:rs606231307).
FT                                {ECO:0000269|PubMed:17334708}.
FT                                /FTId=VAR_054401.
FT   VARIANT     412    412       K -> E (in dbSNP:rs9013).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_022092.
FT   HELIX         9     20       {ECO:0000244|PDB:3E9K}.
FT   HELIX        27     35       {ECO:0000244|PDB:3E9K}.
FT   HELIX        40     45       {ECO:0000244|PDB:3E9K}.
FT   HELIX        51     53       {ECO:0000244|PDB:3E9K}.
FT   HELIX        59     61       {ECO:0000244|PDB:3E9K}.
FT   TURN         73     75       {ECO:0000244|PDB:3E9K}.
FT   HELIX        83     97       {ECO:0000244|PDB:3E9K}.
FT   HELIX        98    102       {ECO:0000244|PDB:3E9K}.
FT   STRAND      104    107       {ECO:0000244|PDB:3E9K}.
FT   HELIX       109    111       {ECO:0000244|PDB:3E9K}.
FT   HELIX       114    117       {ECO:0000244|PDB:3E9K}.
FT   HELIX       118    120       {ECO:0000244|PDB:3E9K}.
FT   HELIX       121    124       {ECO:0000244|PDB:3E9K}.
FT   HELIX       128    130       {ECO:0000244|PDB:3E9K}.
FT   STRAND      131    133       {ECO:0000244|PDB:3E9K}.
FT   HELIX       137    148       {ECO:0000244|PDB:3E9K}.
FT   STRAND      153    155       {ECO:0000244|PDB:3E9K}.
FT   STRAND      157    161       {ECO:0000244|PDB:3E9K}.
FT   HELIX       166    178       {ECO:0000244|PDB:3E9K}.
FT   HELIX       183    186       {ECO:0000244|PDB:3E9K}.
FT   STRAND      187    190       {ECO:0000244|PDB:3E9K}.
FT   HELIX       201    211       {ECO:0000244|PDB:3E9K}.
FT   HELIX       212    214       {ECO:0000244|PDB:3E9K}.
FT   STRAND      215    223       {ECO:0000244|PDB:3E9K}.
FT   TURN        225    227       {ECO:0000244|PDB:3E9K}.
FT   HELIX       233    242       {ECO:0000244|PDB:3E9K}.
FT   STRAND      246    250       {ECO:0000244|PDB:3E9K}.
FT   TURN        252    257       {ECO:0000244|PDB:3E9K}.
FT   HELIX       262    265       {ECO:0000244|PDB:3E9K}.
FT   STRAND      269    272       {ECO:0000244|PDB:3E9K}.
FT   STRAND      274    276       {ECO:0000244|PDB:3E9K}.
FT   STRAND      287    290       {ECO:0000244|PDB:3E9K}.
FT   HELIX       292    294       {ECO:0000244|PDB:3E9K}.
FT   TURN        295    297       {ECO:0000244|PDB:3E9K}.
FT   HELIX       305    307       {ECO:0000244|PDB:3E9K}.
FT   HELIX       310    313       {ECO:0000244|PDB:3E9K}.
FT   HELIX       326    329       {ECO:0000244|PDB:3E9K}.
FT   HELIX       336    352       {ECO:0000244|PDB:3E9K}.
FT   HELIX       354    375       {ECO:0000244|PDB:3E9K}.
FT   STRAND      388    390       {ECO:0000244|PDB:3E9K}.
FT   HELIX       396    398       {ECO:0000244|PDB:3E9K}.
FT   STRAND      403    407       {ECO:0000244|PDB:3E9K}.
FT   HELIX       414    419       {ECO:0000244|PDB:3E9K}.
FT   TURN        420    422       {ECO:0000244|PDB:3E9K}.
FT   STRAND      426    428       {ECO:0000244|PDB:3E9K}.
FT   TURN        429    431       {ECO:0000244|PDB:3E9K}.
FT   STRAND      432    436       {ECO:0000244|PDB:3E9K}.
FT   TURN        439    441       {ECO:0000244|PDB:3E9K}.
FT   HELIX       444    458       {ECO:0000244|PDB:3E9K}.
SQ   SEQUENCE   465 AA;  52352 MW;  BDD136BE18C79EBB CRC64;
     MEPSSLELPA DTVQRIAAEL KCHPTDERVA LHLDEEDKLR HFRECFYIPK IQDLPPVDLS
     LVNKDENAIY FLGNSLGLQP KMVKTYLEEE LDKWAKIAAY GHEVGKRPWI TGDESIVGLM
     KDIVGANEKE IALMNALTVN LHLLMLSFFK PTPKRYKILL EAKAFPSDHY AIESQLQLHG
     LNIEESMRMI KPREGEETLR IEDILEVIEK EGDSIAVILF SGVHFYTGQH FNIPAITKAG
     QAKGCYVGFD LAHAVGNVEL YLHDWGVDFA CWCSYKYLNA GAGGIAGAFI HEKHAHTIKP
     ALVGWFGHEL STRFKMDNKL QLIPGVCGFR ISNPPILLVC SLHASLEIFK QATMKALRKK
     SVLLTGYLEY LIKHNYGKDK AATKKPVVNI ITPSHVEERG CQLTITFSVP NKDVFQELEK
     RGVVCDKRNP NGIRVAPVPL YNSFHDVYKF TNLLTSILDS AETKN
//
